Abstract: Disclosed herein are FABP4 and FABP5 inhibitor compounds and their use in pharmaceutical compositions for treating diseases relating to fatty acid metabolism, including cancer. Also disclosed herein are methods for preparing the disclosed compounds.
Type:
Application
Filed:
September 14, 2022
Publication date:
May 18, 2023
Applicant:
Novius Therapeutics, LLC
Inventors:
Liraz Levi, Tej Pareek, Elizabeth Meyers, Seunghwan Lim, William J. Greenlee, Seong-Jin Kim